The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk factors associated with a second primary lung cancer (SPLC) in patients (pts) with a previous initial primary lung cancer (IPLC).
 
Misako Nagasaka
Consulting or Advisory Role - AstraZeneca
Research Funding - Tempus
 
Dina Farhat
No Relationships to Disclose
 
Kimberly Belzer
Speakers' Bureau - Genentech; Merck
 
Seongho Kim
No Relationships to Disclose
 
Hirva Mamdani
Consulting or Advisory Role - Tempus
 
Ammar Sukari
Speakers' Bureau - Eisai; Merck
Research Funding - Eisai
 
Mary Ann Milczuk
No Relationships to Disclose
 
Ann G. Schwartz
No Relationships to Disclose
 
Antoinette J. Wozniak
Consulting or Advisory Role - Array BioPharma; AstraZeneca; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Coherus Biosciences; Epic; Hospira; Huron Consulting; HUYA Bioscience International; Karyopharm Therapeutics; Premier, Inc.; Quintiles; Takeda; WCCT Global
Research Funding - Boehringer Ingelheim